rabeprazole
UkraineDrugs containing this active substance
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.
Form: capsules, enteric-coated
Active substance Dosage rabeprazole 10 mg ATC: A02BC04
Manufacturer: Intervetia Helskeia Ltd
-
The drug is used for the treatment of gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori bacteria in combination with antibiotics.
Form: capsules, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
Manufacturer: Intervetia Helskeia Ltd
-
The drug is used to treat gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibiotics.
Form: tablets, enteric-coated
Active substance Dosage rabeprazole 10 mg ATC: A02BC04
Manufacturer: Mepro Pharmaceuticals Private Limited
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.
Form: tablets, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
Manufacturer: Mepro Pharmaceuticals Private Limited
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger–Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.
Form: tablets, enteric-coated
Active substance Dosage rabeprazole 10 mg ATC: A02BC04
Manufacturer: Bosch Pharmaceuticals Ltd. (manufacturing of unpackaged product)
-
The drug is used for the treatment of peptic gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibacterial agents.
Form: tablets, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
Manufacturer: Bosch Pharmaceuticals Ltd. (manufacturing of unpackaged product)
-
The drug is used in cases where oral administration is not possible. It is prescribed for the exacerbation of gastric or duodenal ulcers with bleeding, for the short-term treatment of reflux disease with erosions, for the prevention of acid reflux into the esophagus, as well as for Zollinger–Ellison syndrome.
Form: lyophilisate for solution for injection
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
Manufacturer: Cadila Pharmaceuticals Limited
-
The drug is used for the treatment of gastric and duodenal peptic ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibacterial agents.
Form: tablets, film-coated, enteric-coated
Active substance Dosage rabeprazole 10 mg ATC: A02BC04
Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)
-
The drug is used for the treatment of peptic gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori bacteria in combination with antibacterial agents.
Form: tablets, film-coated, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger–Ellison syndrome. It is also used for the eradication of Helicobacter pylori bacteria in combination with antibacterial agents.
Form: tablets, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger–Ellison syndrome. It is also used to eradicate Helicobacter pylori bacteria in combination with antibiotics.
Form: tablets, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
Manufacturer: Tulip Lab Pvt. Ltd.
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori bacteria in combination with antibiotics.
Form: tablets, coated, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori bacteria in combination with antibacterial agents.
Form: tablets, coated, enteric-coated
Active substance Dosage rabeprazole 10 mg ATC: A02BC04
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used for the treatment of peptic gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.
Form: tablets, coated, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
Manufacturer: Torrent Pharmaceuticals Ltd
-
The drug is used to treat gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used to eradicate Helicobacter pylori bacteria in combination with antibiotics.
Form: tablets, enteric-coated
Active substance Dosage rabeprazole 20 mg ATC: A02BC04
-
The drug is used to treat gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used to eradicate Helicobacter pylori in combination with antibiotics.
Form: tablets, enteric-coated
Active substance Dosage rabeprazole 10 mg ATC: A02BC04